Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
about
Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.Surgical management of splenic marginal zone lymphoma.Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
P2860
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@en
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@nl
type
label
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@en
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@nl
prefLabel
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@en
Splenic marginal zone lymphoma ...... proaches in the rituximab era.
@nl
P2093
P1433
P1476
Splenic marginal zone lymphoma ...... pproaches in the rituximab era
@en
P2093
Alessandro Pulsoni
Antonietta Ferretti
Gianna Maria D'Elia
Giorgia Annechini
P356
10.1016/J.LEUKRES.2016.03.005
P577
2016-03-22T00:00:00Z